Integrative analysis illustrates the role of PCDH7 in lung cancer development, cisplatin resistance, and immunotherapy resistance: an underlying target
Background: Cisplatin resistance is a common clinical problem in lung cancer. However, the underlying mechanisms have not yet been fully elucidated, highlighting the importance of searching for biological targets.Methods: Bioinformatics analysis is completed through downloaded public data (GSE21656,...
Main Authors: | Huakang Li, Haoran Xu, Hong Guo, Kangming Du, Diang Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1217213/full |
Similar Items
-
PCDH7 Inhibits the Formation of Homotypic Cell-in-Cell Structure
by: Chenxi Wang, et al.
Published: (2020-05-01) -
Unraveling the Role of PCDH9 in Breast Cancer and Identifying Therapeutic Strategies for PCDH9-Deficient Tumors
by: Li R, et al.
Published: (2024-09-01) -
Genetic variants and phenotype analysis in a five-generation Chinese pedigree with PCDH19 female-limited epilepsy
by: Wenjuan Zhou, et al.
Published: (2023-03-01) -
Histone ubiquitination-related gene CUL4B promotes lung adenocarcinoma progression and cisplatin resistance
by: Yanjun Yin, et al.
Published: (2023-11-01) -
Mapping the Interface between New World Hantaviruses and Their Receptor, PCDH1
by: Megan M. Slough, et al.
Published: (2020-06-01)